OPEN TRIAL OF PRIMSTAT SYRUP UTILIZING TYMPANOCENTESIS IN PEDIATRIC PATIENTS

使用鼓室穿刺术对儿科患者进行 PRIMSTAT 糖浆的公开试验

• 批准号: 5219036
• 负责人: DAVID Peter MCCORMICK
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5219036
• 关键词: antibiotics; child (0-11); clinical research; drug screening /evaluation; ear disorder chemotherapy; ear disorder diagnosis; human subject; human therapy evaluation; longitudinal human study; otitis media; pediatric pharmacology; pediatrics

The purpose of this study is to evaluate the safety and efficacy of Primstat Syrup in the treatment of acute otitis media in children. The study will utilize tympanocentesis on visit one (day 0) and two (day 4) to determine the bacterial efficacy of the antibiotic. There will be two additional followup visits on days 15 and 30.

本研究的目的是评价 Primstat糖浆治疗儿童急性中耳炎。 的 研究将在访视1（第0天）和访视2（第4天）时进行鼓室穿刺术 以确定抗生素的细菌效力。 将有两 在第15天和第30天进行额外随访访视。